Welcome to CNDR
The Center for Neurodegenerative Disease Research (CNDR) promotes and conduct s multidisciplinary clinical and basic research studies aimed at increasing our0 understanding of the causes and mechanisms leading to brain dysfunction and degeneration in Alzheimer's disease (AD), Parkinson's disease (PD), Frontotemporal disease (FTD), amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), and other neurodegenerative disorders that occur more frequently with advancing age.
What's New?
- Living Longer, Living Well: Practical Tips for Successful Aging - October 28th, 2pm, Kaplen JCC on the Palisades, Tenafly, NJ. More information...
- Penn Scientists Test Novel Medication to Block Progression of Alzheimer’s Disease. More Information...
- CNDR receives $500,000 gift from Bilger Foundation to identify new approaches and unique drug targets for the treatment of Alzheimer’s disease and, through its Drug Discovery Center, translate these research findings into new therapeutic drugs. More information...
- Penn Study Finds Way to Prevent Protein Clumping Characteristic of Parkinson’s Disease. More information...
